Pharma Pulse 1/23/25: Technology’s Role in Trial Design Optimization, Trump's Impact on Medicare Drug Price Negotiations & more

Technology’s Role in Trial Design Optimization

In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, highlights how artificial intelligence, real-time monitoring, and historical data can aid in optimizing trial design.

Trump Impact on Medicare Drug Price Negotiations Uncertain

Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and experimental pricing models for gene therapies. But so far the healthcare elements of the Inflation Reduction Act remain unchanged.

DeepMind’s Hassabis Sees AI-Designed Drug Trials This Year

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer.
E-prescribing Market Focused Insights 2024-2029, with Key Vendor Profiles of Surescripts, DrFirst, Practice Fusion, RXNT, CoverMyMeds, Greenway Health and Qualifacts

The "E-prescribing Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The global e-prescribing market is forecast to grow at a CAGR of 21.87% from 2023 to 2029, reaching a projected US $5.57 Billion by 2029.

The global e-prescribing market report consists of exclusive data on 28 vendors. The market is witnessing rapid growth, driven by international and regional players offering solutions with advanced features like clinical decision support and electronic prior authorization. The market is expected to expand further as new vendors collaborate with established software providers. While the large players dominate, several mid-sized and emerging vendors such as DrFirst, Qualifacts, and Practice Fusion are gaining market traction, especially in niche areas like stand-alone solutions for small practices or private clinics.

The Agency Network at MJH Life Sciences on LinkedIn

An insightful article by our very own Group Art Supervisor, Robert Giorgio.

Read below via Pharmaceutical Executive, “The Science Behind Effective #Advertising and #Marketing. How neuroscience drives impactful marketing and advertising.”

#TheAgencyThatWorks #Insights #CreativeMarketing

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs